ID Rhabdomyosarcoma Regimen

Known as: ID Regimen, IRS-IV ID Regimen, Ifosfamide-Doxorubicin Rhabdomyosarcoma Regimen 
A regimen consisting of ifosfamide and doxorubicin used for the treatment of high-risk childhood rhabdomyosarcoma.
National Institutes of Health

Related topics

Related topics

3 relations
DoxorubicinIfosfamidechildhood rhabdomyosarcoma

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children.
INTRODUCTION Children are at risk of rabies exposure in many Asian countries. The safety and immunogenicity profile of the WHO… (More)
Is this relevant?
2003
2003
The challenge to provide affordable rabies post-exposure treatment.
Treatment with Semple or suckling mouse brain rabies vaccines persists in many countries of Asia, Africa and South America. Its… (More)
Is this relevant?